Icon

ENVARSUS XR (nda206406)- (EQ 0.75MG BASE,EQ 1MG BASE,EQ 4MG BASE)

TACROLIMUS VELOXIS PHARMS INC
EQ 0.75MG BASE,EQ 1MG BASE,EQ 4MG BASE
Yes Yes
2028-Aug-30 Expired
2022-Jul-10 None
None No
ENVARSUS XR is a calcineurin-inhibitor immunosuppressant indicated for: • The prophylaxis of organ rejection in de novo kidney transplant patients in combination with other immunosuppressants • The prophylaxis of organ rejection in kidney transplant patients converted from tacrolimus immediate-release formulations in combination with other immunosuppressants.
0 0 0
Total Other Developers 17
Drugs with Suitability No
EQ 0.75MG BASE ** ** - - -
EQ 1MG BASE ** ** - - -
EQ 4MG BASE ** ** - - -
NDA Sales Available Total Generic Sales Available
Yes 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.